From: Severe pneumococcal pneumonia: impact of new quinolones on prognosis
Characteristics | Overall population n = 70 | Group A n = 38 | Group B n = 32 | p |
---|---|---|---|---|
Age (years) | 63.8 ± 16.8 | 63.5 ± 16.5 | 64.1 ± 17.4 | 0.87 |
Male | 53 (75.7%) | 30 (78.9%) | 23 (71.9%) | 0.49 |
Female | 17 (24.3%) | 8 (21.1%) | 9 (28.1%) | |
Malignancy | 5 (7.1%) | 3 (7.9%) | 2 (6.3%) | 0.70 |
Diabetes mellitus | 11 (15.7%) | 4 (10.5%) | 7 (21.8%) | 0.19 |
Chronic heart failure | 11 (15.7%) | 5 (13.1%) | 6 (18.7%) | 0.52 |
Chronic respiratory insufficiency | 12 (17.1%) | 3 (7.9%) | 9 (28.1%) | 0.02 |
Immunosuppression | 13 (18.5%) | 9 (23.6%) | 4 (12.5%) | 0.23 |
SAPS II | 52.9 ± 19.5 | 53.3 ± 20.3 | 52.5 ± 18.9 | 0.86 |
LOD score | 7.3 ± 4.0 | 7.6 ± 4.0 | 6.8 ± 4.0 | 0.40 |
SOFA score | 8.3 ± 3.9 | 9.0 ± 4.1 | 7.5 ± 3.5 | 0.10 |
PSI 4 | 21 (30%) | 14 (36.8%) | 7 (21.9%) | 0.17 |
PSI 5 | 49 (70%) | 24 (63.2%) | 25 (78.1%) | |
Temperature (°C) | 37.9 ± 1.5 | 38.2 ± 1.4 | 37.5 ± 1.5 | 0.04 |
ARF requiring MV | 55 (78.5%) | 30 (78.9%) | 25 (78.1%) | 0.93 |
Septic shock | 34 (48.5%) | 17 (44.7%) | 17 (53.1%) | 0.48 |
Bacteremia | 25 (35.7%) | 9 (23.6%) | 16 (50%) | 0.02 |